HIV-1 Nef dimerization is required for Nef-mediated receptor downregulation and viral replication.
Nef, a human immunodeficiency virus type 1 (HIV-1) accessory factor capable of interaction with a diverse array of host cell signaling molecules, is essential for high-titer HIV replication and AIDS progression. Previous biochemical and structural studies have suggested that Nef may form homodimers and higher-order oligomers in HIV-infected cells, which may be required for both immune and viral receptor downregulation as well as viral replication. Using bimolecular fluorescence complementation, we provide the first direct evidence for Nef dimers within HIV host cells and identify the structural requirements for dimerization in vivo. Bimolecular fluorescence complementation analysis shows that the multiple hydrophobic and electrostatic interactions found within the dimerization interface of the Nef X-ray crystal structure are essential for dimerization in cells. Nef dimers localized to the plasma membrane as well as the trans-Golgi network, two subcellular localizations essential for Nef function. Mutations in the Nef dimerization interface dramatically reduced both Nef-induced CD4 downregulation and HIV replication. Viruses expressing dimerization-defective Nef mutants were disabled to the same extent as HIV that fails to express Nef in terms of replication. These results identify the Nef dimerization region as a potential molecular target for antiretroviral drug discovery.
Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, E1240 Biomedical Science Tower, Pittsburgh, PA 15261, USA.
Jerrod A
JA
Poe
Thomas E
TE
Smithgall
D019380:Anti-HIV Agents / Q000737:chemistry / Q000494:pharmacology; D015704:CD4 Antigens / Q000378:metabolism; D002460:Cell Line; D018360:Crystallography, X-Ray; D015536:Down-Regulation; D015195:Drug Design; D005453:Fluorescence; D015497:HIV-1 / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D011487:Protein Conformation; D055503:Protein Multimerization / Q000187:drug effects; D014779:Virus Replication; D054311:nef Gene Products, Human Immunodeficiency Virus / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*
D019380:Anti-HIV Agents; D015704:CD4 Antigens; D054311:nef Gene Products, Human Immunodeficiency Virus; C514837:nef protein, Human immunodeficiency virus 1